UnitedHealth Group (NYSE:UNH) Stock Price Down 0% – Time to Sell?

UnitedHealth Group Incorporated (NYSE:UNH) dropped 0% during trading on Thursday . The company traded as low as $514.46 and last traded at $518.19. Approximately 530,279 shares traded hands during trading, a decline of 87% from the average daily volume of 4,071,972 shares. The stock had previously closed at $518.20.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 0.0 %

The company has a market capitalization of $471.51 billion, a PE ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The stock has a fifty day moving average of $508.81 and a two-hundred day moving average of $544.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company earned $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC purchased a new stake in UnitedHealth Group in the third quarter worth $341,000. Principal Financial Group Inc. increased its stake in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Kingfisher Capital LLC boosted its stake in UnitedHealth Group by 1.2% during the third quarter. Kingfisher Capital LLC now owns 2,923 shares of the healthcare conglomerate’s stock worth $1,709,000 after acquiring an additional 36 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of UnitedHealth Group by 0.9% during the third quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate’s stock valued at $123,054,000 after purchasing an additional 1,789 shares during the last quarter. Finally, Fred Alger Management LLC increased its position in UnitedHealth Group by 91.9% during the 3rd quarter. Fred Alger Management LLC now owns 199,460 shares of the healthcare conglomerate’s stock valued at $116,620,000 after buying an additional 95,503 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.